tuneTypical Dose
3-5 g
Natural Compound
Creatine monohydrate (N-aminoiminomethyl-N-methylglycine)
tuneTypical Dose
3-5 g
watchEffect Window
1-2 weeks with loading phase, or 3-4 weeks with maintenance dose alone, to reach muscle saturation.
check_circleCompliance
WADA NOT PROHIBITED
Overview
Creatine supports rapid ATP regeneration as phosphocreatine in muscle and brain. It is used to increase strength and power output and to support lean mass gains with resistance training.
Strong evidence shows improved strength, power, and training volume, leading to greater lean mass gains during resistance programs. Recent meta-analyses continue to support small but meaningful improvements in lean mass and strength when creatine is paired with training, with the clearest strength signal in younger adults and less uniform results in women and older adults. A newer randomized trial also highlights that some early DXA lean-mass gain reflects wash-in and body-water effects rather than extra hypertrophy. Repeated sprint performance benefits are consistent. Minority research suggests cognitive benefits under sleep deprivation and in older adults, likely through brain energy buffering. Weight gain from water retention is common and can confound body composition interpretation.
Increases intramuscular phosphocreatine stores, enabling rapid ATP regeneration during high-intensity activity. Secondary effects include cell volumization and potential neuroprotection via brain ATP support.
Article
Creatine is a small molecule built from three amino acids: arginine, glycine, and methionine. Your body synthesizes it primarily in the liver, with minor contributions from the pancreas and kidneys. Once made, it travels through the bloodstream and gets taken up by tissues that need it most. Skeletal muscle holds over 95% of your total stores, with the remainder distributed across the brain, heart, kidneys, and eyes.
The core function of creatine is deceptively simple: it donates a phosphate group to ADP, regenerating ATP. ATP is the universal energy currency of the cell, and during high-intensity effort, your muscles burn through it faster than mitochondria can replenish it. Creatine phosphate (phosphocreatine) acts as a rapid-response buffer, plugging that gap. A typical 70 kg male carries roughly 120 grams of total creatine, with stores replenishing through both dietary intake and endogenous synthesis.
---
Meat is the primary dietary source. Raw beef contains roughly 4.7-5.5 g/kg, chicken and rabbit each around 3.4 g/kg, and cardiac tissue from ox around 2.5 g/kg. Organ meats like liver, kidney, and lung contain very little, under 0.25 g/kg. Dairy products provide trace amounts, with dried skim milk containing about 0.88% creatine by weight. Human breast milk contains 60-70 micromoles per liter.
The average American male aged 19-39 consumes roughly 1 gram of creatine per day through diet, while women average around 0.64 grams. Both figures fall short of the commonly cited 2 g/day estimate.1
Cooking degrades creatine. Around 30% of meat-bound creatine converts to the inactive metabolite creatinine, or is lost in cooking exudate, by the time meat reaches medium-well. Creatine also participates in the formation of heterocyclic amines at high temperatures, though marination partially inhibits this process.
Your body produces creatine in a two-step process. First, arginine and glycine combine via the enzyme AGAT to form guanidoacetate. Then, guanidoacetate receives a methyl group from S-adenosyl methionine (SAMe) via the enzyme GAMT, yielding creatine. Deficiencies in either enzyme, rare but documented, cause serious neurological impairment, including intellectual disability and autism-like symptoms. Neurons can also synthesize their own creatine locally, independent of systemic supply.
Creatine synthesis consumes a substantial share of the body's available methyl groups. Estimates suggest up to 40% of SAMe methylation capacity goes toward creatine production. When you supplement, synthesis is downregulated through negative feedback on AGAT, freeing SAMe for other methylation processes. This has downstream implications for homocysteine metabolism and potentially liver health.
---
During explosive or sustained high-intensity effort, ATP depletes rapidly. Phosphocreatine donates its phosphate group to ADP through the creatine kinase (CK) enzyme, regenerating ATP faster than any other mechanism in the cell. The CK enzyme exists in multiple tissue-specific isoforms: muscle CK (MCK) in skeletal and cardiac muscle, brain CK (BCK) in neurons and glial cells, and mitochondrial variants of each. This system operates in both the cytosol and mitochondria, linking energy transfer across compartments.
Higher phosphocreatine stores correlate directly with greater contractile force and power output.2 The ratio of phosphocreatine to creatine in a cell also acts as a metabolic signal, suppressing AMPK activity when energy is abundant and allowing it to activate when energy is low.
When creatine enters a cell, it draws water in with it. This swelling, often dismissed as mere "water weight," is actually a potent anabolic signal. Cell swelling activates MAPK stress kinases (p38 and JNK), heat shock protein 27, and downstream pathways including GSK3β and MEF2 that promote muscle cell growth and differentiation. Swelling also directly stimulates glycogen synthesis, independent of glucose uptake.3
Separately, phosphocreatine can bind directly to cell membrane phospholipids, stabilizing them against oxidative and mechanical stress. This effect is independent of the CK enzyme system and has been demonstrated in synthetic membrane models.
Because creatine synthesis consumes so much SAMe, supplementing creatine reduces that demand. SAMe is the body's primary methyl donor, involved in DNA methylation, neurotransmitter synthesis, and phosphatidylcholine production. By reducing its consumption, creatine supplementation may preserve SAMe availability for other processes, analogous to how trimethylglycine (betaine) functions. This mechanism likely underlies creatine's observed ability to reduce homocysteine and protect against fatty liver in animal models.
---
The brain has a complex and tightly regulated relationship with creatine. Neurons synthesize their own creatine, and the blood-brain barrier expresses the creatine transporter SLC6A8 to take creatine up from circulation. However, transport is actively regulated. Injecting large doses of creatine into rodents raises brain creatine by less than 1% above baseline. This tight regulation means that supplementation does not "superload" the brain the way it does muscle tissue.
This matters for interpreting the cognitive effects of creatine supplementation. In people who are already creatine-replete, healthy omnivores with normal brain metabolism, supplementation has limited cognitive impact. Where it does show clear benefit is in populations with suboptimal creatine status: vegetarians, vegans, sleep-deprived individuals, and the elderly.4
In vegetarians, who lack the primary dietary source of creatine and tend to have lower circulating levels, supplementation reliably improves memory, processing speed, and learning. This effect is largely absent in omnivores under normal conditions, suggesting the benefit is about correcting a relative deficiency rather than providing supraphysiological advantage.
The brain's creatine system is also implicated in neuroprotection. By buffering ATP, creatine protects neurons against excitotoxicity, hypoxia, and the toxic effects of compounds like MPTP (a Parkinson's model neurotoxin). Creatine also modulates the NMDA receptor at its polyamine binding site, increasing glutamate sensitivity and potentially enhancing learning. This is a mechanism shared with D-aspartic acid.
---
Creatine monohydrate has excellent bioavailability, approximately 99% at standard doses of 5-10 grams. The intestinal transporter responsible is SLC6A8, a sodium- and chloride-dependent transporter, the same one that handles uptake in muscle and brain. At doses above 10 grams, intestinal absorption can saturate, resulting in increased fecal excretion and, in some cases, gastrointestinal discomfort.
After a 5 gram dose, serum creatine rises from baseline levels of 50-100 micromoles per liter to 600-800 micromoles within an hour. Muscle uptake reaches saturation at serum concentrations achievable with standard 5 gram doses, which is one reason larger single doses offer diminishing returns.
Creatine is metabolized to creatinine at a steady rate of about 1.6-1.7% of total stores per day, and roughly 2 grams of creatinine is excreted daily in urine in a typical 70 kg male. This daily loss sets the minimum dietary or supplemental requirement to maintain stores. After ceasing supplementation, blood creatine returns to baseline within roughly 28 days, though elevated muscle stores may persist for up to six weeks.5
A loading protocol (20 grams per day in four divided doses for 5-7 days) rapidly saturates muscle stores, producing a 15-20% increase above baseline in responders. A standard maintenance dose of 3-5 grams per day achieves the same saturation over three to four weeks, simply more slowly. The physiological endpoint is identical.
For athletes with high training volumes, 2 grams per day, often cited as a "maintenance" dose, may be insufficient to sustain elevated stores. A 5 gram daily maintenance is more practical for active individuals.
Insulin promotes creatine uptake into muscle cells. Taking creatine alongside carbohydrates, or in proximity to a meal that stimulates insulin secretion, can meaningfully enhance muscular uptake, particularly during the first few days of loading when stores are depleted.
---
Not everyone benefits equally from creatine supplementation. Responders show a greater than 20 mmol/liter increase in muscle creatine content. Non-responders show less than 10 mmol/liter increase. A "quasi-responder" middle group exists between those thresholds.
Responders tend to be younger, carry more muscle mass, and have a higher proportion of type II (fast-twitch) muscle fibers. Dietary protein intake does not predict response. Type II fibers preferentially accumulate creatine over type I fibers, which helps explain why people with more fast-twitch muscle respond more dramatically.
Non-response likely explains the null results seen in some trials. Studies that stratify by response status tend to find significant effects where whole-group analyses do not.
---
The evidence for creatine improving strength and power output is among the most robust in sports nutrition. A meta-analysis of 16 placebo-controlled trials found that creatine supplementation increased bench press strength by approximately 6.85 kg and squat strength by 9.76 kg over eight weeks, compared to training alone. A second meta-analysis calculated an effect size for exercises under 30 seconds, those relying on the phosphocreatine system, and found that creatine enhanced performance by an additional 4.2% above exercise alone, bringing the total improvement to 7.5%.6
These benefits apply across sexes and across trained and untrained individuals. The rate of strength gain during a resistance training program appears to be up to 78% greater with creatine compared to placebo.
During repeated sprint efforts with short rest periods, phosphocreatine resynthesis rate is a primary determinant of subsequent sprint performance. Creatine supplementation improves power output in anaerobic cardiovascular exercise and has been shown to increase lactate threshold and time to volitional fatigue. The benefit is clearest for efforts under 30 seconds and diminishes with longer bouts or longer rest intervals.
Creatine does not enhance VO2 max or endurance performance in healthy individuals. The added body water from loading does not impair aerobic performance in well-trained athletes, but it also does not provide a measurable benefit. In hot environments, creatine's water retention may reduce perceptions of heat stress and attenuate serotonin-mediated fatigue, which can indirectly support performance.
Beyond strength, creatine promotes muscle hypertrophy through multiple mechanisms. It increases cellular water content, directly enlarging muscle fiber diameter (type I fibers by ~9%, type IIa by ~5%, type IIx by ~4% after loading). Cell swelling reduces protein breakdown, upregulates over 200 genes involved in muscle anabolism, and increases the expression of proteins in the PI3K/Akt/mTOR pathway. Creatine also suppresses myostatin, a negative regulator of muscle growth, while preserving satellite cell recruitment signals.7
---
Vegetarians and vegans have consistently lower baseline creatine stores than omnivores because skeletal muscle, the primary dietary source, is absent from their diets. This creates a relative deficiency state that supplementation corrects rather than superpowers.
In young vegetarians, creatine supplementation reliably enhances cognition, working memory, and processing speed in ways that are not observed in omnivores. The increase in lean mass from supplementation may also be proportionally greater in vegetarians. Supplementation normalizes the gap in muscle creatine stores between vegetarians and omnivores.8
This matters beyond athletic performance. There is a documented correlation between vegetarian and vegan dietary patterns and elevated rates of anxiety and depression in survey data. Whether creatine deficiency contributes to this association is an open question, but it is physiologically plausible given creatine's role in brain bioenergetics and its involvement in serotonergic and dopaminergic neurotransmission.
---
Creatine has legitimate mechanistic connections to mood regulation. Brain energy metabolism is impaired in depression, and phosphocreatine systems show reduced activity in the brains of depressed patients on imaging. Creatine modulates both serotonin and dopamine signaling, and in animal models, its antidepressant effects depend on dopamine receptor activation.
The strongest clinical evidence comes from a double-blind, placebo-controlled trial in women with major depressive disorder, where 5 grams of creatine daily added to SSRI therapy produced significantly faster and more complete antidepressant response compared to SSRI alone, with benefits appearing by week two.9
Sex appears to matter here. Female rats and female humans consistently show stronger antidepressant responses to creatine than males. Lower creatine kinase activity in women, combined with altered purine metabolism during depression, may make the female brain more sensitive to creatine's bioenergetic effects. One open-label study also found that creatine supplementation triggered hypomanic episodes in two bipolar patients, suggesting caution in that population.
---
Creatine monohydrate is the reference form, the most studied, most cost-effective, and functionally equivalent to all alternatives. It is 88% creatine by weight. Micronized versions improve solubility but are otherwise identical.
Creatine anhydrous removes the water molecule from monohydrate, yielding 100% creatine by weight. It reconverts to monohydrate in water. Useful for high-concentration capsule formulas, otherwise equivalent.
Creatine HCl is bound to hydrochloric acid. The acid dissociates in the stomach, leaving free creatine, effectively equivalent to monohydrate. Claims of lower required dosage have not been tested in humans.
Creatine ethyl ester is largely ineffective. It degrades into creatinine in the intestinal environment before reaching muscle, and direct comparison studies show it performs no better than placebo while producing higher serum creatinine levels.
Buffered creatine (Kre-Alkylyn) has been marketed as superior due to higher pH. A direct comparison against monohydrate in 36 resistance-trained subjects found no significant differences in muscle creatine content, body composition, performance, or side effects.
Liquid creatine is ineffective for commercial products. Creatine degrades passively to creatinine over several days in solution. Preparing your own creatine shake immediately before consumption is not a problem, but pre-mixed liquid products lose potency on the shelf.
Creatine pyruvate reaches higher peak plasma creatine levels compared to isomolar monohydrate in one study, with possible performance advantages at low doses. This result has not been replicated.
Magnesium chelate, creatine citrate, creatine malate, and creatine nitrate all appear equivalent to monohydrate in ergogenic effect. Citrate and malate offer improved water solubility. Nitrate adds potential vasodilatory effects from the nitrate moiety, but direct comparison to monohydrate shows no additional performance benefit.
For practical purposes, monohydrate remains the default recommendation.
---
The current evidence suggests that taking creatine in proximity to training, either pre- or post-workout, is marginally superior to taking it at an unrelated time of day. The most parsimonious interpretation is that exercise upregulates the creatine transporter through metabolic stress, making muscle more receptive to creatine uptake around training sessions.10
Between pre- and post-workout timing, available evidence leans slightly toward post-workout, though no study has shown a statistically significant whole-group difference.
Practical recommendations:
---
The safety record of creatine monohydrate is extensive. Multiple systematic reviews and long-term clinical trials have found no adverse effects on kidney function, liver enzymes, or general health markers across a wide range of doses and durations.11
The known side effects are practical rather than pathological. High single doses (above 10 grams) can cause gastrointestinal discomfort due to intestinal transporter saturation. Inadequate hydration relative to increased total body water can cause cramping. Neither effect occurs at standard dosing with adequate fluid intake.
Creatine raises serum creatinine through normal metabolic conversion, not through kidney damage. This can produce false-positive results on kidney function panels, a well-documented diagnostic confounder that clinicians should be aware of.
People with pre-existing kidney conditions warrant caution. While studies in diabetics, hemodialysis patients, and people with single kidneys have not shown harm from creatine at standard doses, the evidence in these populations is less extensive than in healthy individuals. Those with polycystic kidney disease have particular reason for caution, as creatine accelerated disease progression in a rat model of that condition. Consulting a physician before supplementing is appropriate for anyone with kidney disease or significant risk factors.
---
Traumatic brain injury: In children and adults with TBI, 400 mg/kg daily for six months significantly reduced headache frequency (from 93.8% to 11.1%), fatigue, and dizziness in an open-label study. Animal data show creatine supplementation can halve injury severity following experimental brain trauma, operating through mitochondrial membrane preservation.
Muscular dystrophies: In Duchenne muscular dystrophy (DMD), 100 mg/kg daily over four months increased handgrip strength and lean mass in boys, with more parents reporting subjective benefit with creatine than placebo. Similar modest benefits have been observed in mixed dystrophinopathies.
Mitochondrial myopathies: Creatine supplementation consistently improves physical performance and quality of life in patients with mitochondrial cytopathies, likely because it partially compensates for impaired mitochondrial ATP production.
Myotonic dystrophy: Results are mixed. DM1 patients appear non-responsive, possibly because reduced creatine transporter expression prevents muscular accumulation. DM2 patients showed improved subjective wellbeing in one trial despite no change in power output.
Osteoarthritis: Women with knee osteoarthritis experienced a 52% reduction in stiffness, 45% reduction in pain, and 41% improvement in physical function after 12 weeks of creatine combined with mild exercise, without changes in objective power output.
Pregnancy (animal data): Maternal creatine supplementation in rodents increases fetal creatine stores in the brain, heart, liver, and kidneys, and substantially improves survival and growth outcomes following birth hypoxia (simulating caesarean section complications). Human data does not yet exist, but the mechanistic rationale is compelling.
---
Creatine is absorbed through skin rapidly, roughly 52% within one hour of topical application, and accumulates primarily in the stratum corneum. Topical creatine at 0.02% concentration in a face cream formulation reduced wrinkle depth and jowl volume over six weeks. In fibroblasts, creatine stimulates procollagen secretion to approximately 450% of baseline. Combination with folic acid further enhances skin firmness. The mechanism involves supporting cellular energy availability in dermal and epidermal cells, which is reduced with age and UV exposure.
---
Caffeine: Coingesting caffeine during creatine loading may partially negate creatine's ergogenic effects, possibly through opposing effects on muscle contraction time. However, caffeine taken before individual workouts, without being coingested during daily creatine loading, does not impair creatine's performance benefits and may synergize with them. The practical strategy is to load creatine daily and use caffeine selectively around workouts rather than simultaneously during the loading phase.
Carbohydrates: Insulin stimulates creatine transporter activity. Coingesting creatine with carbohydrates meaningfully enhances muscle uptake during the initial loading window.
Beta-alanine: Combined creatine and beta-alanine supplementation over four weeks produced superior body composition changes (greater muscle gain, greater fat loss) compared to creatine alone.
Alpha-lipoic acid (ALA): 1,000 mg ALA combined with creatine and sucrose increased muscular creatine accumulation above creatine plus sucrose alone, suggesting ALA enhances uptake through insulin-sensitizing mechanisms.
COX-2 inhibitors: Creatine and COX-2 inhibitors show additive neuroprotection against dopaminergic neurotoxicity in animal models, with particular relevance to Parkinson's disease risk.
---
The choice between loading and maintenance-only protocols is not just about speed. It has practical implications for adherence, GI comfort, and context.
Loading (20 g/day in four divided 5 g doses for 5 to 7 days) saturates stores in about one week. This is useful for athletes entering a competition phase who need to be creatine-replete quickly. The downside is that some people experience bloating, GI discomfort, or significant water retention during the loading window, which can be distracting or unwelcome depending on the sport and weight class.
Maintenance-only (3 to 5 g/day from day one) reaches the same saturation endpoint in 3 to 4 weeks. There is no performance penalty at the end state. The only cost is the 2 to 3 week delay before full stores are achieved. For recreational trainees, general health supplementation, or anyone who experiences GI issues with higher doses, maintenance-only is the more practical path.12
For larger individuals (over 90 kg lean body mass) or athletes with very high training volumes, 5 g/day is more appropriate than 3 g/day for maintenance. The 1.7% daily turnover rate means that larger muscle mass loses more creatine to creatinine conversion each day, and 3 g may not fully replace those losses.
One often-overlooked consideration is that stopping and restarting creatine (for example during an off-season break) means stores deplete over 4 to 6 weeks. If you plan to resume, a brief 3-day loading phase at 10 to 15 g/day can accelerate re-saturation without the full 7-day loading protocol.
---
Vegetarians and vegans respond disproportionately well to creatine supplementation because they start from a lower baseline. Without dietary meat, the primary exogenous creatine source is absent, and endogenous synthesis alone does not fully compensate.
Studies consistently show that vegetarians have 20 to 30% lower muscle creatine stores compared to omnivores. This gap means that the relative increase from supplementation is proportionally larger. A vegetarian going from depleted to saturated muscle stores may experience a more noticeable performance and cognitive benefit than an omnivore whose stores were already partially replete from diet.8
The cognitive benefit is particularly notable. In vegetarian populations, creatine supplementation has been shown to improve working memory, reduce mental fatigue, and enhance processing speed in controlled trials. These effects are largely absent in well-nourished omnivores, reinforcing the interpretation that creatine's cognitive benefits operate primarily through correcting a relative deficiency rather than providing supraphysiological advantage.
For vegetarian and vegan athletes, creatine supplementation is one of the most evidence-based and cost-effective interventions available. It addresses a genuine nutritional gap that plant-based diets create, and the benefits span both physical performance and cognitive function.
---
The brain uses approximately 20% of the body's resting energy despite representing only 2% of body mass. This extreme metabolic demand makes the brain especially vulnerable to energy disruptions, which is exactly what happens during traumatic brain injury (TBI) and concussion.
Following TBI, mitochondrial function is impaired, ATP production drops, and the brain enters an energy crisis that can persist for days to weeks. Creatine's role as a rapid ATP buffer makes it a mechanistically logical intervention for neuroprotection in this context.
In animal models, pre-loading with creatine before experimental brain injury reduces cortical damage by up to 50%, preserves mitochondrial membrane potential, and reduces biomarkers of oxidative injury. The protective effect is dose-dependent and more effective when creatine is present in the brain before injury occurs rather than administered after.13
Human data is limited but directionally positive. An open-label study in children and adolescents with TBI found that 400 mg/kg/day creatine for 6 months significantly reduced headache frequency (from 93.8% to 11.1%), dizziness, and fatigue. While this study lacked blinding and placebo control, the magnitude of improvement was striking.
The practical implication for contact sport athletes is that maintaining creatine-replete status through daily supplementation creates a neuroenergetic buffer that may reduce the severity of concussion-related energy crisis if injury occurs. This is not a treatment for acute concussion. It is a pre-loading strategy that ensures the brain has maximal phosphocreatine reserves available when they are needed most.
---
Creatine research has historically been dominated by studies in young men. The female evidence base is growing and reveals some important sex-specific patterns.
Women generally have lower baseline creatine stores than men, partly because they tend to have less total muscle mass and partly because dietary creatine intake is often lower (women eat less meat on average). This means the relative benefit of supplementation may be proportionally larger in women, similar to the vegetarian advantage.
For strength and body composition, the evidence in women is positive but less uniform than in men. Some studies report significant strength gains, while others report improvements in body composition without statistically significant strength changes. The inconsistency may reflect the smaller absolute magnitude of change in women (making statistical significance harder to achieve in small studies) rather than a true absence of effect.14
For mood and depression, the female-specific data is particularly interesting. The strongest clinical depression trial (Lyoo et al.) was conducted in women with major depressive disorder, and the effect was robust. Female rats consistently show stronger antidepressant responses to creatine than male rats. Lower creatine kinase activity in women may make the female brain more sensitive to creatine's bioenergetic effects.
For menstrual cycle considerations, creatine's water retention effect may temporarily increase scale weight during the luteal phase when water retention is already elevated. This is cosmetic and physiologically benign, but it can confound body composition tracking. Advise female users to compare body composition measurements at the same cycle phase rather than across phases.
---
Taking creatine with carbohydrates meaningfully enhances muscle creatine uptake, and the mechanism is well understood. Insulin stimulates the SLC6A8 creatine transporter in skeletal muscle, increasing the rate at which creatine moves from blood into muscle cells.
The practical threshold appears to be around 50 to 100 grams of carbohydrate co-ingested with creatine. At this level, the insulin response is sufficient to enhance uptake during the loading phase. During maintenance, when stores are already near saturation, the benefit of carbohydrate co-ingestion is smaller because uptake is limited by available storage capacity rather than transport rate.15
For most people, taking creatine with a normal meal that contains carbohydrates is sufficient. There is no need for specialized high-glycemic index loading protocols. A meal with rice, bread, fruit, or any other carbohydrate source will produce enough insulin to support creatine uptake.
---
One of the most persistent concerns about creatine is that it causes hair loss. This claim traces back to a single 2009 study in college-age rugby players that found a statistically significant increase in dihydrotestosterone (DHT) during a creatine loading protocol. DHT is the androgen primarily responsible for androgenetic alopecia (male pattern baldness).
The study reported a 56% increase in DHT during loading, though levels remained within the normal clinical range. The DHT elevation returned toward baseline during the maintenance phase. No hair loss was measured or reported in the study.16
This single finding has not been replicated in subsequent creatine studies that measured androgen profiles. Multiple trials measuring testosterone, free testosterone, and DHT in creatine users have found no significant changes. A 2021 systematic review and meta-analysis examining creatine's effects on testosterone found no statistically significant impact.
The most likely explanation for the original finding is a statistical artifact from a small sample with high baseline variability, combined with the use of an aggressive loading protocol in a specific population. Even if the DHT increase were real and reproducible, a transient increase within the normal range during a 7-day loading phase would not be expected to produce clinically meaningful hair loss.
For people with active androgenetic alopecia who are concerned, the evidence does not support avoiding creatine. The single positive finding is far outweighed by the body of null results and the absence of any clinical hair loss data.
---
Creatine's long-term safety record is more extensive than for virtually any other sports supplement. Studies spanning months to years in diverse populations, including children, elderly adults, patients with neuromuscular disease, and competitive athletes, have consistently found no adverse effects on kidney function, liver enzymes, electrolyte balance, or hematological markers.17
The longest prospective safety data comes from studies in patients with neuromuscular disorders who supplemented creatine for 1 to 4 years continuously, and from retrospective analyses of athletes who have used creatine for 5 or more years. In all of these contexts, renal function (measured by GFR, serum creatinine corrected for muscle mass, and cystatin C) remained stable.
The International Society of Sports Nutrition has issued position statements confirming that creatine monohydrate is the most effective and safest ergogenic supplement available, with no evidence of harm at recommended doses in healthy populations. The American College of Sports Medicine has similarly noted creatine's safety profile.
The key qualification remains kidney disease. While studies in diabetics and people with single kidneys have shown no harm, the evidence in advanced chronic kidney disease is limited. People with polycystic kidney disease have specific reason for caution based on the animal model data mentioned earlier. For everyone else, the long-term safety evidence supports indefinite use at standard doses.
---
Sarcopenia, the progressive loss of muscle mass and function with aging, is one of the most significant health challenges in older populations. Creatine supplementation has emerged as a particularly relevant intervention in this context because it addresses multiple pathways involved in age-related muscle decline.
Older adults have lower baseline muscle creatine stores compared to younger adults. They also have reduced creatine kinase activity and lower rates of phosphocreatine resynthesis after effort. Supplementation can partially normalize these deficits, improving the energetic environment for muscle contraction and adaptation to resistance training.18
Meta-analyses of creatine supplementation in older adults (typically 50 to 70 years and above) paired with resistance training show significant improvements in upper- and lower-body strength, lean mass, and functional performance measures. The strength gains are consistent enough that creatine is now recommended by several expert panels as an adjunct to resistance training in older adults at risk for sarcopenia.
Beyond muscle, creatine's potential brain energy benefits are relevant for aging. Cognitive decline in older adults is associated with reduced brain creatine and phosphocreatine levels. Preliminary evidence suggests creatine supplementation can improve certain cognitive tasks in older adults, though the data is less robust than the physical performance evidence.
For practical application, older adults should use standard maintenance dosing (3 to 5 g/day) and pair supplementation with resistance training for maximum benefit. Loading protocols are optional and may cause more GI discomfort in older populations. Adequate hydration is important, as older adults often have reduced thirst drive. There is no upper age limit for creatine use based on current evidence.
---
Creatine kinase activity varies substantially by sex, race, and training status, independent of supplementation. Males exhibit higher CK activity than females. Black individuals show higher activity than Hispanic individuals, who in turn show higher activity than white individuals. These differences are more pronounced in men. Exercise increases both the mean and the variance of CK activity. Understanding these population-level differences matters when interpreting CK levels on bloodwork.
---
Average dietary creatine intake derived from NHANES III survey data in adults aged 19-39.
↩The ratio of ATP to ADP in a muscle cell directly predicts contractile capacity. Phosphocreatine elevation improves this ratio.
↩Glycogen synthesis responds directly to osmotic cell swelling via PI3K/mTOR signaling, not glucose uptake changes.
↩Brain creatine uptake is tightly regulated. Superloading creatine raises brain concentrations by less than 1% above baseline in rodent models.
↩Blood creatine returns to baseline within 28 days post-supplementation. Elevated muscle stores may persist somewhat longer.
↩Meta-analysis data from Branch (2003) and Dempsey, Mazzone, and Meurer (2002).
↩Creatine-induced myostatin suppression occurred without changes in GASP-1, the primary endogenous myostatin inhibitor.
↩Vegetarian supplementation normalizes muscle creatine stores to omnivore levels and restores cognitive performance gaps.
↩Lyoo et al. (2012), randomized double-blind placebo-controlled trial. Improvements in prefrontal N-acetylaspartate and neural connectivity were also documented.
↩Exercise-induced ROS and metabolic stress activate SGK1/SGK3 kinases, upregulating the creatine transporter acutely.
↩International Society of Sports Nutrition position stand (Kreider et al., 2017) comprehensively reviewed creatine safety across populations and dose ranges.
↩Maintenance-only dosing (3-5 g/day) reaches the same muscle saturation endpoint as loading protocols within 3-4 weeks, with no difference in the final steady-state creatine stores.
↩Animal models of TBI show creatine pre-loading reduces cortical damage by up to 50% and preserves mitochondrial membrane potential, with stronger protection when creatine is present before injury.
↩Female-specific creatine evidence shows positive but less statistically uniform strength outcomes compared to males, likely reflecting smaller absolute effect magnitudes in study populations rather than absence of biological effect.
↩Co-ingestion of 50-100 grams of carbohydrate with creatine enhances muscle uptake through insulin-mediated stimulation of the SLC6A8 creatine transporter, with the largest benefit during the initial loading phase.
↩The single 2009 study reporting DHT elevation during creatine loading found levels remained within normal clinical range, and no subsequent studies have replicated the finding. No hair loss was measured in any creatine trial.
↩Prospective safety data spanning 1-4 years in neuromuscular disease patients and retrospective analyses of 5+ year athletic use show stable renal function, liver enzymes, and electrolyte balance.
↩Meta-analyses in older adults show creatine plus resistance training produces significant improvements in upper- and lower-body strength, lean mass, and functional performance measures relevant to sarcopenia prevention.
↩Outcomes
Safety
Evidence
Buford TW, et al. "International Society of Sports Nutrition position stand: creatine supplementation and exercise." J Int Soc Sports Nutr. 2007.
Population: Athletes / Active Adults
Key findings: Creatine monohydrate is the most effective ergogenic nutritional supplement currently available to athletes in terms of increasing high-intensity exercise capacity and lean body mass during training.
Creatine monohydrate is the most effective ergogenic nutritional supplement currently available to athletes in terms of increasing high-intensity exercise capacity and lean body mass during training.
Effect of creatine supplementation during resistance training on muscle strength: systematic review and meta-analysis. 2024. PMID:39519498.
Population: Trained and untrained adults completing resistance training programs.
Dose protocol: Most included studies used creatine monohydrate with resistance training for multiple weeks.
Key findings: Updated meta-analysis supported greater strength gains with creatine supplementation during resistance training versus placebo.
Notes: Effect size depends on baseline training status and program quality.
Updated meta-analysis supported greater strength gains with creatine supplementation during resistance training versus placebo.
Creatine supplementation augments body composition benefits from resistance training in adults: systematic review and meta-analysis. 2024. PMID:39074168.
Population: Adults participating in resistance training interventions.
Dose protocol: Trials generally used loading then 3-5 g/day maintenance or steady daily dosing.
Key findings: Meta-analysis showed a small but consistent favorable effect on lean mass and fat-free mass during training interventions.
Notes: Body composition interpretation should separate early water retention from longer-term training adaptation.
Meta-analysis showed a small but consistent favorable effect on lean mass and fat-free mass during resistance training interventions.
Zhang H, Lan T, Yan X, Gu H, Li Y, He E. Effects of creatine supplementation on muscle strength gains-a meta-analysis and systematic review. PeerJ. 2025;13:e20380. doi:10.7717/peerj.20380. PMID:41328071.
Population: Middle-aged and older adults participating in resistance-training interventions.
Dose protocol: Creatine supplementation paired with resistance training in middle-aged and older adults across multiweek interventions.
Key findings: Updated meta-analysis supported stronger resistance-training outcomes in middle-aged and older adults, including upper- and lower-body strength gains.
Notes: Extends the strength evidence into older cohorts rather than materially changing first-line dosing.
Updated meta-analysis supported greater upper- and lower-body strength gains and favorable hypertrophy-related outcomes when creatine was paired with resistance training in middle-aged and older adults.
Kazeminasab F, Kerchi AB, Sharafifard F, Zarreh M, Forbes SC, Camera DM, Lanhers C, Wong A, Nordvall M, Bagheri R, Dutheil F. The Effects of Creatine Supplementation on Upper- and Lower-Body Strength and Power: A Systematic Review and Meta-Analysis. Nutrients. 2025;17(17):2748. doi:10.3390/nu17172748. PMID:40944139.
Population: Adults across 69 randomized studies of creatine with resistance training, other exercise modalities, or no exercise.
Dose protocol: Creatine was most often paired with resistance training across multiweek interventions.
Key findings: Recent meta-analysis found significant improvements in bench or chest press, squat, vertical jump, and Wingate peak power, but not every strength test improved uniformly.
Notes: Useful for keeping claims specific because effects were more robust in younger adults and men than in some other subgroups.
Recent pooled evidence supports small but significant improvements in bench or chest press strength, squat strength, and selected power outcomes when creatine is paired with training, while handgrip and leg press effects remain less consistent. Benefits were more robust in younger adults and men than in older adults and women in subgroup analyses.
Desai I, Pandit A, Smith-Ryan AE, Simar D, Candow DG, Kaakoush NO, Hagstrom AD. The Effect of Creatine Supplementation on Lean Body Mass with and Without Resistance Training. Nutrients. 2025;17(6):1081. doi:10.3390/nu17061081. PMID:40292479.
Population: Healthy adults completing a creatine wash-in plus 12-week resistance training study.
Dose protocol: Creatine monohydrate 5 g/day with a 7-day wash-in followed by 12 weeks of resistance training.
Key findings: Lean body mass increased during the wash-in period, but the same trial did not show extra lean-mass growth during the subsequent shared training block.
Notes: Helpful corrective source for overinterpreting early DXA lean-mass changes as pure muscle gain.
This trial suggests that part of creatine's early lean-mass increase reflects wash-in effects, while additional DXA lean-mass gain during training was not greater than control at 5 g/day in this design.